Fatigue typically resolves by week six to eight, replaced by improved energy as weight loss progresses and sleep quality improves
GLP-1 related drug development process Naturally secreted GLP-1 peptides are rapidly degraded by the ubiquitous enzyme dipeptidyl peptidase-4 (DPP-4), rendering them unsuitable for direct therapeutic use
Int Ophthalmol 32(6):531538 Gopinathan U et al (2009) Review of epidemiological features, microbiological diagnosis and treatment outcome of microbial keratitis: experience of over a decade
Future Outlook The GLP-1 Drug Market size is projected to reach USD 42.0 billion by 2035, growing at a CAGR of 13.17%, driven by increasing diabetes prevalence, rising obesity rates, and advancements in drug formulations
More pronounced body contouring effectssuch as a slimmer waistline, reduced body fat, and a more defined silhouetteare usually achieved after at least six months of consistent treatment, especially when paired with healthy lifestyle habits
A meta-analysis looked at obese participants with obstructive sleep apnea (OSA) and found they had fewer breathing interruptions at night as they lost weight
